Deletion of Xist in the murine blood compartment induced highly aggressive MDS/MPN suggesting that Xist has a genome-wide impact and acts as a potent suppressor of myeloid blood malignancies [107]. This evidence concerns the gene XIST and myelodysplastic syndrome.